Cargando…

Case report: Non-response to fluoxetine in a homozygous 5-HTTLPR S-allele carrier of the serotonin transporter gene

We report the case of a 50-year-old male with major depressive disorder (MDD) to illustrate the challenge of finding effective antidepressant pharmacotherapy and the role that the patient’s genetic makeup may play. Recent treatment attempts before clinic admission included venlafaxine and fluoxetine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stäuble, Céline K., Meier, Rebecca, Lampert, Markus L., Mikoteit, Thorsten, Hatzinger, Martin, Allemann, Samuel S., Hersberger, Kurt E., Meyer zu Schwabedissen, Henriette E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334565/ https://www.ncbi.nlm.nih.gov/pubmed/35911243 http://dx.doi.org/10.3389/fpsyt.2022.942268

Ejemplares similares

Pharmacist-guided pre-emptive pharmacogenetic testing in antidepressant therapy (PrePGx): study protocol for an open-label, randomized controlled trial
por: Stäuble, Céline K., et al.
Publicado: (2021)

Pharmacogenetic-Guided Antidepressant Selection as an Opportunity for Interprofessional Collaboration: A Case Report
por: Stäuble, Céline K., et al.
Publicado: (2021)

Severe Adverse Drug Reactions to Quetiapine in Two Patients Carrying CYP2D6*4 Variants: A Case Report
por: Stäuble, Céline K., et al.
Publicado: (2021)

A Guide to a Pharmacist-Led Pharmacogenetic Testing and Counselling Service in an Interprofessional Healthcare Setting
por: Stäuble, Céline K., et al.
Publicado: (2022)

Enriching Medication Review with a Pharmacogenetic Profile – A Case of Tamoxifen Adverse Drug Reactions
por: Jeiziner, Chiara, et al.
Publicado: (2021)

Pharmacogenetics in Pharmaceutical Care—Piloting an Application-Oriented Blended Learning Concept
por: Stäuble, Céline K., et al.
Publicado: (2021)

Genotyping of Patients with Adverse Drug Reaction or Therapy Failure: Database Analysis of a Pharmacogenetics Case Series Study
por: Bollinger, Anna, et al.
Publicado: (2023)

Pharmacogenetic Analysis Enables Optimization of Pain Therapy: A Case Report of Ineffective Oxycodone Therapy
por: Wiss, Florine M., et al.
Publicado: (2023)

Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? – A Case Report
por: Jeiziner, Chiara, et al.
Publicado: (2022)

Pharmacogenetic testing and counselling in the community pharmacy: mixed-methods study of a new pharmacist-led service
por: Jeiziner, Chiara, et al.
Publicado: (2023)

The Lack of Influence of Homozygous Long Allele of the 5-HTTLPR Gene on the Severity of Alcohol Craving During 6 Weeks of Rehab Hospitalisation in Comparison to Not Homozygous and Homozygous Short Alleles – Preliminary Report
por: Czarnecki, Damian, et al.
Publicado: (2023)

Vitamin D moderates the interaction between 5-HTTLPR and childhood abuse in depressive disorders
por: Bonk, Sarah, et al.
Publicado: (2020)

Serotonin Transporter Genotype (5-HTTLPR) Predicts Utilitarian Moral Judgments
por: Marsh, Abigail A., et al.
Publicado: (2011)

Modulation of Human Serotonin Transporter Expression by 5-HTTLPR in Colon Cells
por: Prasansuklab, Anchalee, et al.
Publicado: (2011)

On the evolution of the serotonin transporter linked polymorphic region (5-HTTLPR) in primates
por: Dobson, Seth D., et al.
Publicado: (2013)

HLA‐associated adverse drug reactions ‐ scoping review
por: Jeiziner, Chiara, et al.
Publicado: (2021)

Differential serotonin transport is linked to the rh5-HTTLPR in peripheral blood cells
por: Singh, Y S, et al.
Publicado: (2012)

Utilization of Drugs with Pharmacogenetic Dosing Recommendations in Switzerland: A Descriptive Study Using the Helsana Database
por: Wittwer, Nina L, et al.
Publicado: (2022)

Functional serotonin 5–HTTLPR polymorphism is a risk factor for migraine with aura
por: Borroni, B., et al.
Publicado: (2005)

A study of blood serotonin and serotonin transporter promoter variant (5-HTTLPR) polymorphism in Egyptian autistic children
por: Meguid, Nagwa A., et al.
Publicado: (2015)

Seasonal variation of serotonin turnover in human cerebrospinal fluid, depressive symptoms and the role of the 5-HTTLPR
por: Luykx, J J, et al.
Publicado: (2013)

Depressive mood ratings are reduced by MDMA in female polydrug ecstasy users homozygous for the l-allele of the serotonin transporter
por: Kuypers, K. P. C., et al.
Publicado: (2018)

Delayed Serotonin Syndrome in the Setting of a Mixed Fluoxetine and Serotonin Antagonist Overdose
por: Little, Kimberly, et al.
Publicado: (2018)

Bi-allelic and tri-allelic 5-HTTLPR polymorphisms and triptan non-response in cluster headache
por: Schürks, Markus, et al.
Publicado: (2014)

How the serotonin transporter 5-HTTLPR polymorphism influences amygdala function: the roles of in vivo serotonin transporter expression and amygdala structure
por: Kobiella, A, et al.
Publicado: (2011)

Developmental Exposure to Fluoxetine Modulates the Serotonin System in Hypothalamus
por: Berg, Cecilia, et al.
Publicado: (2013)

Serotonin transporter gene polymorphism (5-HTTLPR) L allele interacts with stress to increase anxiety symptoms in Chinese adolescents: a multiwave longitudinal study
por: Ming, Qingsen, et al.
Publicado: (2015)

Influence of the Serotonin Transporter 5HTTLPR Polymorphism on Symptom Severity in Irritable Bowel Syndrome
por: Colucci, Rocchina, et al.
Publicado: (2013)

Parenting and the Serotonin Transporter Gene (5HTTLPR), Is There an Association? A Systematic Review of the Literature
por: Landoni, Marta, et al.
Publicado: (2022)

Intestinal serotonin and fluoxetine exposure modulate bacterial colonization in the gut
por: Fung, Thomas C., et al.
Publicado: (2019)

Behavioral destabilization induced by the selective serotonin reuptake inhibitor fluoxetine
por: Kobayashi, Katsunori, et al.
Publicado: (2011)

Transient Serotonin Toxicity Evoked by Combination of Electroconvulsive Therapy and Fluoxetine
por: Klysner, René, et al.
Publicado: (2014)

The effects of congenital brain serotonin deficiency on responses to chronic fluoxetine
por: Sachs, B D, et al.
Publicado: (2013)

The Serotonin Transporter Polymorphism (5-HTTLPR) and Alcohol Problems in Heavy Drinkers: Moderation by Depressive Symptoms
por: Tartter, Molly A., et al.
Publicado: (2011)

Serotonin Transporter (5-HTTLPR) Genotype and Childhood Trauma are Associated with Individual Differences in Decision Making
por: Stoltenberg, Scott F., et al.
Publicado: (2011)

Serotonin Transporter Polymorphism (5-HTTLPR) and Citalopram Effectiveness in Iranian Patients with Major Depressive Disorder
por: Sahraian, Shima, et al.
Publicado: (2013)

Serotonin Transporter Genotype (5-HTTLPR) and Electrocortical Responses Indicating the Sensitivity to Negative Emotional Cues
por: Papousek, Ilona, et al.
Publicado: (2013)

Evaluation of the promoter region polymorphism (5-HTTLPR) in the serotonin transporter gene in females with postpartum depression
por: ZHANG, XIAOLI, et al.
Publicado: (2015)

Serotonin transporter polymorphism (5HTTLPR), severe childhood abuse and depressive symptom trajectories in adulthood
por: Nguyen, Timothy B., et al.
Publicado: (2015)

Association Between Polymorphism (5-HTTLPR) of the Serotonin Transporter Gene and Behavioral Response to Unfair Distribution
por: Nishina, Kuniyuki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rd7nthq4g83ucbgfr76dloltjv